Search
Patexia Research
Case number 1:20-cv-00445

Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Aug 1, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER: The requested redactions for Exhibits 2 and 3 of the Joinder Letter by Mylan (see D.I. 204 and D.I. 205 in 20-cv-445-RGA; D.I. 665 and D.I. 666 in 1:20-md-02930-RGA) are GRANTED. Ordered by Judge Richard G. Andrews on 8/1/2022. Associated Cases: 1:20-cv-00445-RGA, 1:20-md-02930-RGA(nms)
Jul 26, 2022 221 Redacted Document (8)
Docket Text: REDACTED VERSION of [210] Letter, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 7/26/2022 (nms).
Jul 26, 2022 222 Main Document (409)
Docket Text: REDACTED VERSION of [211] Declaration, by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Part 2, # (2) Part 3, # (3) Part 4)(Joyce, Alexandra) Modified on 7/26/2022 (nms).
Jul 26, 2022 222 Pt. 2 of 4 (41)
Jul 26, 2022 222 Pt. 3 of 4 (173)
Jul 26, 2022 222 Pt. 4 of 4 (125)
Jul 25, 2022 220 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of Supplemental Expert Report of Robin D. Rogers, Ph.D. Against Crystal Pharmaceutical (Suzhou) Co., Ltd., Mylan Pharmaceuticals, Inc., Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Jul 22, 2022 217 Reply Brief (16)
Docket Text: REPLY BRIEF re [206] MOTION to Preclude Defendants' Expert Dr. Fintel from Offering Opinions on Topics Outside His Expertise, filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/24/2022 (nms).
Jul 22, 2022 218 Main Document (4)
Docket Text: DECLARATION of Shannon K. Clark, Esq. re [217] Reply Brief, by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibits I-M)(Silver, Daniel) Modified on 7/25/2022 (nms).
Jul 22, 2022 218 Exhibit I-M (75)
Jul 22, 2022 219 Redacted Document (30)
Docket Text: REDACTED VERSION of [213] Answering Brief in Opposition, by Mylan Pharmaceuticals Inc.. (Hoeschen, Nathan)
Jul 21, 2022 216 Order (6)
Docket Text: SO ORDERED Granting (D.I. 312 in 19-cv-2053-RGA; D.I. 488 in 19-cv-1979-RGA; D.I. 15 in 20-cv-445-RGA; D.I. 690 in 20-md-2930-RGA) Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers. Signed by Judge Richard G. Andrews on 7/21/2022. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-01979-RGA, 1:19-cv-02053-RGA, 1:20-cv-00445-RGA(nms)
Jul 20, 2022 215 Stipulation (6)
Docket Text: STIPULATION Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
Jul 19, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 214 in 20-cv-445-RGA; D.I. 686 in 20-md-2930-RGA; D.I. 485 in 19-cv-1979-RGA) STIPULATION and Order to Extend Time to submit a public version of the Motion to Strike to July 26, 2022. Signed by Judge Richard G. Andrews on 7/19/2022. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-01979-RGA, 1:20-cv-00445-RGA(nms)
Jul 18, 2022 214 Stipulation to EXTEND Time (4)
Docket Text: STIPULATION TO EXTEND TIME to submit a public version of the Motion to Strike to July 26, 2022 - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd.. (Gattuso, Dominick)
Jul 14, 2022 212 Status Report (9)
Docket Text: Joint Status Report, by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/15/2022 (nms).
Jul 12, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 479 in 19-cv-1979-RGA; D.I. 208 in 20-cv-445-RGA; D.I. 674 in 20-md-2930-RGA; D.I. 177 in 19-cv-2021-RGA; D.I. 306 in 19-cv-2053-RGA) Stipulation and Proposed Order to Extend Time Associated Cases: 1:20-md-02930-RGA, 1:19-cv-01979-RGA, 1:19-cv-02021-RGA, 1:19-cv-02053-RGA, 1:20-cv-00445-RGA(nms)
Jul 11, 2022 209 Main Document (3)
Docket Text: MOTION to Strike Exhibits 37-41 and Related Testimony Introduced by Defendants during the June 28, 2022 Deposition Redirect of Dr. Tomislav Friscic - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Proposed Order, # (2) Rule 7.1.1. Certification)(Silver, Daniel) Modified on 7/12/2022 (nms).
Jul 11, 2022 209 Text of Proposed Order (3)
Jul 11, 2022 209 Rule 7.1.1. Certification (3)
Jul 7, 2022 208 Stipulation (7)
Docket Text: STIPULATION and Proposed Order to Extend Time, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 7/7/2022 (nms).
Jul 1, 2022 206 Main Document (9)
Docket Text: MOTION to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside His Expertise - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) 7.1.1. Certification, # (2) Proposed Order)(Silver, Daniel) Modified on 7/5/2022 (nms).
Jul 1, 2022 206 Rule 7.1.1. Certification (1)
Jul 1, 2022 206 Text of Proposed Order (4)
Jul 1, 2022 207 Main Document (4)
Docket Text: DECLARATION of Shannon K. Clark, Esq. re [206] MOTION to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside His Expertise, by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibits A-H)(Silver, Daniel) Modified on 7/5/2022 (nms).
Jul 1, 2022 207 Exhibit A-H (222)
Jun 30, 2022 N/A Oral Argument (0)
Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Hearing on the Motion and Joinders to Strike held on 6/30/2022. Counsel for Plaintiff: D. Silver. Counsel for Defendants: D. Gattuso, A. Poff, B. Palapura. The motion to strike expert reports (No. 20-md-2930, D.I. 622; No. 19-cv-1979, D.I. 456) was resolved as stated at the hearing. The transcript of the hearing shall serve as the order of the Court. (Court Reporter Deanna Warner.) Associated Cases: 1:20-md-02930-RGA, 1:19-cv-01979-RGA, 1:19-cv-02053-RGA, 1:20-cv-00445-RGA (lak)
Jun 28, 2022 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: The declaration filed as an attachment to the letter at D.I. [204] has been removed from that filing. Declarations are to be filed independent of other filings. Counsel is to refile the declaration accordingly. (nms)
Jun 28, 2022 203 Main Document (3)
Docket Text: REDACTED VERSION of [187] Letter, by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibits 1-11)(Palapura, Bindu) Modified on 6/28/2022 (nms).
Jun 28, 2022 203 Exhibit 1-11 (488)
Jun 28, 2022 204 Letter (1)
Docket Text: Letter to The Honorable Richard G. Andrews, from Bindu A. Palapura, regarding redacted filing. (Palapura, Bindu) Modified on 6/28/2022 (nms).
Jun 28, 2022 205 Declaration (2)
Docket Text: DECLARATION of Preston Imperatore re [204] Letter, by Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 6/28/2022 (nms).
Jun 27, 2022 202 Notice to Take Deposition (4)
Docket Text: NOTICE to Take Deposition of Tomislav Friscic, Ph.D. on June 28, 2022 filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Jun 23, 2022 200 Redacted Document (8)
Docket Text: REDACTED VERSION of [194] Letter, by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 6/23/2022 (nms).
Jun 23, 2022 201 Redacted Document (30)
Docket Text: REDACTED VERSION of [195] Declaration, by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 6/23/2022 (nms).
Jun 22, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 199 in 20-cv-445-RGA; D.I. 657 in 20-md-2930-RGA) STIPULATION TO EXTEND TIME to file redactions to June 28, 2022. Signed by Judge Richard G. Andrews on 6/22/2022. Associated Cases: 1:20-md-02930-RGA, 1:20-cv-00445-RGA(nms)
Jun 22, 2022 199 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to file redactions to June 28, 2022 - filed by Mylan Pharmaceuticals Inc.. (Palapura, Bindu)
Jun 21, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 647 in 20-md-2930-RGA; D.I. 197 in 20-cv-445-RGA) STIPULATION and Proposed Order to Extend Time to file redactions to June 22, 2022. Signed by Judge Richard G. Andrews on 6/21/2022. Associated Cases: 1:20-md-02930-RGA, 1:20-cv-00445-RGA(nms)
Jun 20, 2022 198 Notice to Take Deposition (5)
Docket Text: NOTICE to Take Deposition of Robin D. Rogers, Ph.D. on June 21, 2022 (remote) filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Jun 17, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 646 in 20-md-2930-RGA; D.I. 196 in 20-cv-445-RGA; D.I. 468 in 19-cv-1979-RGA; D.I. 293 in 19-cv-2053-RGA; D.I. 174 in 19-cv-2021-RGA) STIPULATION and Proposed Order to Extend Time to submit a joint interim status report to July 7, 2022. Signed by Judge Richard G. Andrews on 6/17/2022. Associated Cases: 1:19-cv-01979-RGA, 1:19-cv-02021-RGA, 1:19-cv-02053-RGA, 1:20-cv-00445-RGA, 1:20-md-02930-RGA(nms)
Jun 17, 2022 196 Stipulation to EXTEND Time (7)
Docket Text: STIPULATION and Proposed Order to Extend Time for the parties to submit a joint interim status report to July 7, 2022 - filed by Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 6/17/2022 (nms).
Jun 17, 2022 197 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION and Proposed Order to Extend Time to file redactions - filed by Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 6/21/2022 (nms).
Jun 16, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER: A hearing on the Motion and Joinders to Strike (D.I. [623]; D.I. [627]; D.I. [631]) is now set for 6/30/2022, at 2:00 PM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 6/16/2022. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-01979-RGA, 1:19-cv-02053-RGA, 1:20-cv-00445-RGA(nms)
Jun 16, 2022 193 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Dr. Gregory Bell, Ph.D. on June 17, 2022 filed by Laurus Generics Inc., Laurus Labs Limited.(Poff, Adam)
Jun 15, 2022 190 Notice to Take Deposition (8)
Docket Text: NOTICE to Take Deposition of Alexander M. Klibanov, Ph.D. on June 16, 2022 (remote) filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Jun 15, 2022 191 Notice to Take Deposition (3)
Docket Text: NOTICE to Take Deposition of Hatem Titi, Ph.D. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Jun 14, 2022 189 Letter (3)
Docket Text: Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding the Courts June 3, 2022 Oral Order concerning patent expiration dates. (Silver, Daniel) Modified on 6/14/2022 (nms).
Jun 13, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 282 in 19-cv-2053-RGA; D.I. 170 in 19-cv-2021-RGA; D.I. 459 in19-cv-1979-RGA; D.I. 628 in 20-md-2930-RGA; D.I. 188 in 20-cv-445-RGA)STIPULATION to Extend Time for the close of expert discovery to complete the depositions. Signed by Judge Richard G. Andrews on 6/13/2022. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-01979-RGA, 1:19-cv-02021-RGA, 1:19-cv-02053-RGA, 1:20-cv-00445-RGA(nms)
Jun 10, 2022 188 Stipulation to EXTEND Time (7)
Docket Text: STIPULATION and Proposed Order Extending Time for the close of expert discovery to complete the depositions - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 6/13/2022 (nms).
Jun 6, 2022 185 Notice (Other) (5)
Docket Text: NOTICE of Defendants' Deposition of Adam J. Matzger, Ph.D. by Crystal Pharmaceutical (Suzhou) Co., Ltd. (Gattuso, Dominick)
Jun 6, 2022 186 Notice to Take Deposition (4)
Docket Text: NOTICE to Take Deposition of Dr. Jonathan W. Steed filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Jun 3, 2022 183 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D. Against Crystal Pharmaceutical (Suzhou) Co., Ltd., Mylan Pharmaceuticals, Inc., Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Jun 3, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER: It appears that the 30 month stay ends no earlier than July 7, 2023. (E.g., No. 19-1979, D.I. 3). Two of the asserted patents (the 659 and the 331) are said to expire on January 14, 2023. (Id.). The other two patents (the 938 and the 134) expire in 2026 and 2027. I think Novartis told me on April 21, 2022, that the first two patents, because of pediatric (or some other) exclusivity, if valid and infringed, would actually block any launch before July 14, 2023. The parties are to advise whether I have all this right. If it is right, I expect to prioritize the invalidity and infringement proceedings relating to the second set of patents. I do not see what sense it makes to invest a lot of time and effort trying cases relating to patents that may have no practical impact and at most would have limited practical impact. If one or more generics (which, by my count, are Biocon, Laurus, Teva, MacLeods, Zydus, Hetero, and DRL (Mylans trials being in West Virginia)) are successful against the later-expiring patents, there will be other ways to resolve the 659 and 331 claims. Ordered by Judge Richard G. Andrews on 6/3/2022. Associated Cases: 1:20-md-02930-RGA et al.(nms)
May 31, 2022 181 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D. Against Crystal Pharmaceutical (Suzhou) Co., Ltd., Mylan Pharmaceuticals, Inc., Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
May 31, 2022 182 Notice to Take Deposition (8)
Docket Text: NOTICE to Take Deposition of Bernhardt L. Trout, Ph.D. on June 1, 2022 filed by Laurus Generics Inc., Laurus Labs Limited.(Poff, Adam)
May 26, 2022 180 Notice to Take Deposition (4)
Docket Text: NOTICE to Take Deposition of Dan Fintel, M.D. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
May 25, 2022 179 Notice to Take Deposition (4)
Docket Text: NOTICE to Take Deposition of Dr. Laird Forrest filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
May 17, 2022 178 Notice to Take Deposition (4)
Docket Text: NOTICE to Take Deposition of Ivan T. Hofmann filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
May 16, 2022 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: The Notice of Service (D.I. 577 in 20md2930-RGA; D.I. 437 in 19cv199-RGA; D.I. 164 19cv2021-RGA; D.I. 258 in 19cv2053-RGA; D.I. 178 in 20cv445-RGA) filed on 5/13/2022, has been removed. The filing contained errors in the caption. Counsel shall refile the Notice of Service and reflect "RGA" after the case numbers. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-01979-RGA, 1:19-cv-02021-RGA, 1:19-cv-02053-RGA, 1:20-cv-00445-RGA(nms)
May 3, 2022 177 Notice of Service (11)
Docket Text: NOTICE OF SERVICE of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov on the Validity of the '659 Patent filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Apr 27, 2022 176 Letter (1)
Docket Text: Letter to The Honorable Richard G. Andrews from David E. Moore regarding case status. (Moore, David)
Apr 21, 2022 N/A Status Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Status/scheduling Conference held on 4/21/2022. Counsel for Plaintiff: D. Silver. Counsel for Defendants: D. Gattuso, K. Keller, J. Miller, D. Bortz, M. Haney, C. Hitch, A. Poff, J. Seaman, S. Stamoulis. The parties shall submit proposed scheduled two weeks from today. (Court Reporter Heather Triozzi.) Associated Cases: 1:20-md-02930-RGA et al.(lak)
Apr 20, 2022 174 Notice of Service (12)
Docket Text: NOTICE OF SERVICE of (1) Sur-Reply Expert Report of Francis G. Spinale, MD, PH.D. regarding Validity and (2) Sur-Reply Report of Gregory K. Bell, Ph.D. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Apr 20, 2022 175 Notice of Service (11)
Docket Text: NOTICE OF SERVICE of Sur-Reply Expert Report of Dr. Alexander M. Klibanov on the Validity of the 659 and 331 Patents filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Apr 12, 2022 N/A Case No Longer Referred to Mediation (0)
Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb)
Apr 11, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER: Due to a scheduling conflict the Status/Scheduling Conference scheduled for 4/20/2022, is CANCELED. The Status/Scheduling Conference is now rescheduled for 4/21/2022, at 2:00 PM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 4/11/2022. Associated Cases: 1:20-md-02930-RGA et al.(nms)
Apr 8, 2022 172 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of (1) Reply Expert Report of Adam J. Matzger, Ph.D. Against Crystal Pharmaceutical (Suzhou) Co., Ltd., Mylan Pharmaceuticals, Inc., Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. and (2) Reply Expert Report of Robin D. Rogers, Ph.D. Against Crystal Pharmaceutical (Suzhou) Co., Ltd., Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd., and Mylan Pharmaceuticals, Inc. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Apr 1, 2022 170 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of Reply Expert Report of Dr. Jonathan W. Steed filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan)
Apr 1, 2022 171 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of the Reply Expert Report of Dan Fintel, M.D., on the Invalidity of the '659 and '331 Patents filed by Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Hetero Labs Limited, Hetero Labs Limited Unit III, Hetero USA Inc.,, Torrent Pharmaceuticals Ltd., Hetero USA Inc..(Ormerod, Eve)
Mar 28, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 169 in 20-cv-445-RGA; D.I. 520 in 20-md-2930-RGA: D.I. 410 in 19-cv-1979-RGA; D.I. 232 in 19-cv-2053-RGA) STIPULATION TO EXTEND TIME to serve reply expert reports concerning infringement to April 7, 2022. Signed by Judge Richard G. Andrews on 3/28/2022. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-01979-RGA, 1:19-cv-02053-RGA, 1:20-cv-00445-RGA(nms)
Mar 25, 2022 169 Stipulation to EXTEND Time (4)
Docket Text: STIPULATION and Proposed Order to Extend Time to serve reply expert reports concerning infringement to April 7, 2022 - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 3/28/2022 (nms).
Mar 21, 2022 168 Status Report (17)
Docket Text: JOINT Status Report, by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 3/22/2022 (nms).
Mar 16, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER: The parties to the MDL and its member cases are to file a joint status report no later than three (3) days from the date of this Order. Specifically the parties should address (1) scheduled deadlines and events currently in place, (2) matters that are outstanding and need Court attention, and (3) for the cases related to the MDL but not member cases of the MDL, what the relationship is, including in particular what overlap (for example, the same patents, different patents but the same patent family, the same branded products, the same generic products) the related cases have with the member cases. Ordered by Judge Richard G. Andrews on 3/16/2022. Associated Cases: 1:20-md-02930-RGA et al.(nms)
Mar 15, 2022 N/A Case Assigned/Reassigned (0)
Docket Text: Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-01979-RGA, 1:19-cv-02021-RGA, 1:19-cv-02053-RGA, 1:20-cv-00074-RGA and 1:20-cv-00445-RGA (rjb)
Mar 15, 2022 166 Order (1)
Docket Text: ORDER in MDL No. 2930 Reassigning Litigation to Judge Richard G. Andrews. Signed by Karen K. Caldwell, Chair on 3/15/22. Associated Cases: 1:20-md-02930-LPS et al. (ntl)
Feb 11, 2022 164 Notice of Service (17)
Docket Text: NOTICE OF SERVICE of (1) Responsive Expert Report of Francis G. Spinale, MD, PHD Regarding Validity of the 659 and 331 Patents; (2) Responsive Expert Report of Dr. Alexander M. Klibanov on the Validity of the 659 and 331 Patents; and (3) Expert Report of Gregory K. Bell, PH.D. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Feb 11, 2022 165 Notice of Service (9)
Docket Text: NOTICE OF SERVICE of Responsive Expert Report of Bernhardt L. Trout, Ph.D. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Dec 15, 2021 162 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Opening Expert Report of Dan Fintel, M.D., on the Invalidity of the '659 and '331 Patents filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Hetero Labs Limited, Hetero Labs Limited Unit III, Hetero USA Inc..(Ormerod, Eve)
Dec 15, 2021 163 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Opening Expert Report of Laird Forrest Regarding Invalidity of U.S. Patent Nos. 8,101,659 and 8,796,331 filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories, Inc..(Stamoulis, Stamatios)
Dec 14, 2021 161 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Expert Report of Dr. Jonathan W. Steed filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc..(Weinblatt, Richard)
Nov 24, 2021 160 Redacted Document (3)
Docket Text: REDACTED VERSION of (412 in 1:20-md-02930-LPS, 158 in 1:20-cv-00445-LPS) Stipulation by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
Nov 16, 2021 159 Redacted Document (17)
Docket Text: REDACTED VERSION of (196 in 1:19-cv-02053-LPS, 114 in 1:20-cv-00415-LPS, 339 in 1:19-cv-01979-LPS, 132 in 1:19-cv-02021-LPS, 35 in 1:21-cv-00229-LPS, 106 in 1:20-cv-00074-LPS, 157 in 1:20-cv-00445-LPS, 407 in 1:20-md-02930-LPS) Status Report by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
Nov 9, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Whitney M. Howard for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-md-02930-LPS et al.(srs)
Nov 8, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (156 in 1:20-cv-00445-LPS, 131 in 1:19-cv-02021-LPS, 105 in 1:20-cv-00074-LPS, 195 in 1:19-cv-02053-LPS, 337 in 1:19-cv-01979-LPS, 405 in 1:20-md-02930-LPS, 113 in 1:20-cv-00415-LPS) MOTION for Pro Hac Vice Appearance of Attorney Whitney Meier Howard filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 11/8/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl)
Nov 5, 2021 156 Main Document (3)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Whitney Meier Howard - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Certification for Whitney Meier Howard)(Silver, Daniel)
Nov 5, 2021 156 Certification for Whitney Meier Howard (1)
Nov 4, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (336 in 1:19-cv-01979-LPS, 104 in 1:20-cv-00074-LPS, 404 in 1:20-md-02930-LPS, 194 in 1:19-cv-02053-LPS, 130 in 1:19-cv-02021-LPS, 155 in 1:20-cv-00445-LPS, 112 in 1:20-cv-00415-LPS, 34 in 1:21-cv-00229-LPS) STIPULATION TO EXTEND TIME the Deadline for the Submissionof the Joint Status Report to November 8, 2021 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 11/4/21. Associated Cases: 1:19-cv-01979-LPS et al. (ntl)
Nov 3, 2021 155 Stipulation to EXTEND Time (12)
Docket Text: STIPULATION TO EXTEND TIME the Deadline for the Submissionof the Joint Status Report to November 8, 2021 - filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel)
Oct 21, 2021 153 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Responses And Objections To Novartis's Fourth Set Of Requests To Mylan Pharmaceuticals Inc. For The Production Of Documents And Things (Nos. 75-76) [Highly Confidential Attorneys' Eyes Only]; Mylan Pharmaceuticals Inc.'s Responses And Objections To Novartis's Third Set Of Interrogatories (No. 6) To Mylan Pharmaceuticals Inc. [Highly Confidential Attorneys' Eyes Only]; Mylan Pharmaceuticals Inc.'s Responses And Objections To Novartis's First Set Of Requests For Admission To Mylan Pharmaceuticals Inc. [Highly Confidential Attorneys' Eyes Only]; and Mylan Pharmaceuticals Inc.'s Second Supplemental Responses And Objections To Novartis's Second Set Of Interrogatories To Mylan Pharmaceuticals Inc. (Nos. 3-5) [Highly Confidential Attorneys' Eyes Only] filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Oct 21, 2021 154 Notice of Service (18)
Docket Text: NOTICE OF SERVICE of (1) Novartis's Objections and Responses to Defendants' First Set of Requests for Admission (Nos. 1-18); (2) Novartis's Objections and Responses to Defendant Teva's First Set of Requests for Admissions (Nos. 1-9); (3) Novartis's Objections and Responses to Defendant Teva's First Set of Individual Interrogatories (Nos. 1-9); and (4) Novartis's Objections and Responses to Defendant Zydus's First Set of Requests for Admissions (Nos. 1-8) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Oct 20, 2021 151 Notice of Service (14)
Docket Text: NOTICE OF SERVICE of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3 filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Oct 20, 2021 152 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Michael Motto on October 22, 2021 filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Oct 19, 2021 150 Notice of Service (19)
Docket Text: NOTICE OF SERVICE of Discovery Responses filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Oct 14, 2021 149 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Responses And Objections To Novartis's Notice Of Deposition Under Fed. R. Civ. P. 30(b)(6) To Mylan Pharmaceuticals Inc. [Highly Confidential Attorneys' Eyes Only] filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Oct 1, 2021 148 Notice to Take Deposition (8)
Docket Text: NOTICE to Take Deposition of Michael Exton on October 5, 2021 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Stamoulis, Stamatios)
Sep 21, 2021 147 Notice of Service (21)
Docket Text: NOTICE OF SERVICE of (1) Novartis's Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) to Defendants, (2) Novartis's Third Set Of Interrogatories To Defendants, (3) Novartis's Fourth Set of Requests to Defendants for the Production of Documents and Things, (4) Novartis's First Set Of Requests For Admissions To Defendants, and (5) Novartis's Second Set of Common Interrogatories to Defendants filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Sep 20, 2021 146 Notice of Service (19)
Docket Text: NOTICE OF SERVICE of (1) Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff Pursuant to Fed. R. Civ. P. 30(b)(6) and (2) Plaintiff's Second Supplemental Infringement Contentions Against Defendants filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Sep 17, 2021 145 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Defendants' Supplemental Joint Invalidity Contentions filed by Alkem Laboratories Ltd., Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc..(Dorsney, Kenneth)
Sep 15, 2021 136 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Yugang Liu on on a mutually agreed-upon date filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Sep 15, 2021 137 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Sven Erik Godtfredsen on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Sep 15, 2021 138 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Paul Sutton on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Sep 15, 2021 139 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Bin Hu on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Sep 15, 2021 140 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Lili Feng on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Sep 15, 2021 141 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Mahavir Prashad on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Sep 15, 2021 142 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Michael J. Girgis on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Sep 15, 2021 143 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Piotr Karpinski on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Sep 15, 2021 144 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Thomas J. Blacklock on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Sep 14, 2021 135 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Defendant Crystal Pharma's Second Set of Individual Interrogatories (No. 4) to Plaintiff Novartis Pharmaceuticals Corporation filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Sep 8, 2021 133 Notice to Take Deposition (19)
Docket Text: NOTICE to Take Deposition of NOVARTIS PHARMACEUTICALS CORPORATION on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Sep 8, 2021 134 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Randy Lee Webb on September 24, 2021 filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Aug 31, 2021 132 Notice of Service (20)
Docket Text: NOTICE OF SERVICE of (1) Plaintiff's First Supplemental Infringement Contentions Against Defendants, and (2) Novartis's First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories (Nos. 1-3) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Aug 27, 2021 131 Notice of Service (15)
Docket Text: NOTICE OF SERVICE of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-7) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Jul 14, 2021 130 Answer to Counterclaim (16)
Docket Text: ANSWER to [129] Answer to Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Jun 23, 2021 129 Answer to Complaint (27)
Docket Text: ANSWER to Complaint (Amended Complaint - D.I. 127), Affirmative Defenses, and, COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Mylan Pharmaceuticals Inc..(Moore, David)
Jun 18, 2021 128 Transcript (115)
Docket Text: Official Transcript of Claim Construction Hearing held on June 8, 2021 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, email: gaffigan@verizon.net. Transcript may be viewed at the court public terminal or ordered/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 7/9/2021. Redacted Transcript Deadline set for 7/19/2021. Release of Transcript Restriction set for 9/16/2021. (bpg)
Jun 9, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (250 in 1:20-md-02930-LPS, 85 in 1:19-cv-02021-LPS, 66 in 1:20-cv-00415-LPS, 236 in 1:19-cv-01979-LPS, 13 in 1:21-cv-00229-LPS, 115 in 1:20-cv-00445-LPS, 63 in 1:20-cv-00074-LPS, 133 in 1:19-cv-02053-LPS) STIPULATION and [Proposed] Order Regarding Plaintiff Novartis Pharmaceuticals Corporation's Amended Complaints. Signed by Judge Leonard P. Stark on 6/9/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl)
Jun 9, 2021 127 Main Document (14)
Docket Text: AMENDED COMPLAINT against Mylan Pharmaceuticals Inc.- filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-D)(Silver, Daniel)
Jun 9, 2021 127 Exhibit A-D (67)
Jun 9, 2021 127 Amended Complaint* (1)
Jun 8, 2021 N/A Markman Hearing (0)
Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Markman Hearing (by remote video) held on 6/8/2021. (Court Reporter B. Gaffigan.) Associated Cases: 1:20-md-02930-LPS et al. (ntl)
Jun 8, 2021 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel)
Jun 8, 2021 N/A Oral Order (0)
Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 6/8/2021. Associated Cases: 1:19-cv-02021-LPS, 1:19-cv-02053-LPS, 1:20-cv-00074-LPS, 1:20-cv-00415-LPS, 1:20-cv-00445-LPS(dlb)
Jun 7, 2021 125 Main Document (3)
Docket Text: Letter to Chief Judge Leonard P. Stark from Daniel M. Silver, Esq. regarding Dispute Letter - re (261 in 1:20-md-02930-LPS) Order,,. (Attachments: # (1) Exhibit A)(Silver, Daniel)
Jun 7, 2021 125 Exhibit A (38)
Jun 3, 2021 N/A Order (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Markman hearing on June 8, 2021 at 10:00 a.m. is available to the public using the following dial-in for audio access: +1 646 828 7666 US -- Meeting ID: 161 238 3790 -- Passcode: 824345 -- One Tap Mobile Public Dial-In Number: +16468287666,,1612383790#,,,,*824345# US. Audio reproduction of the proceeding is strictly prohibited. ORDERED by Judge Leonard P. Stark on 6/3/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl)
May 25, 2021 123 Main Document (2)
Docket Text: Letter to Chief Judge Leonard P. Stark from Daniel M. Silver, Esq. regarding Claim Construction Hearing. (Attachments: # (1) Exhibit 58)(Silver, Daniel)
May 25, 2021 123 Exhibit 58 (13)
May 24, 2021 N/A Order (0)
Docket Text: ORAL ORDER: Having reviewed the parties' letter concerning the claim construction hearing scheduled for June 8 at 10:00 a.m. (C.A. No. 20-md-2930 D.I. 256), IT IS HEREBY ORDERED that each side will be allocated 75 minutes for its presentation. The hearing will be conducted by videoconference technology. Defendants shall submit access information for the Court, including access information for any interested member of the public, in advance of the hearing. The parties may present argument in the order they propose in the letter. IT IS FURTHER ORDERED that each party shall submit any slides or other materials to be referenced at the hearing by no later than June 7 at 4:00 p.m. ORDERED by Judge Leonard P. Stark on 5/24/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl)
May 21, 2021 118 Joint Claim Construction Brief (30)
Docket Text: JOINT CLAIM CONSTRUCTION BRIEF filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel)
May 21, 2021 119 Main Document (16)
Docket Text: APPENDIX re (14 in 1:21-cv-00229-LPS) Joint Claim Construction Brief, (88 in 1:19-cv-02021-LPS) Joint Claim Construction Brief, (69 in 1:20-cv-00415-LPS) Joint Claim Construction Brief, (118 in 1:20-cv-00445-LPS) Joint Claim Construction Brief, (136 in 1:19-cv-02053-LPS) Joint Claim Construction Brief, (253 in 1:20-md-02930-LPS) Joint Claim Construction Brief, (239 in 1:19-cv-01979-LPS) Joint Claim Construction Brief, (66 in 1:20-cv-00074-LPS) Joint Claim Construction Brief (Volume 1 -- Exhibits A-D) by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-D)(Silver, Daniel)
May 21, 2021 119 Exhibit A-D (431)
May 21, 2021 120 Main Document (16)
Docket Text: APPENDIX re (14 in 1:21-cv-00229-LPS) Joint Claim Construction Brief, (88 in 1:19-cv-02021-LPS) Joint Claim Construction Brief, (69 in 1:20-cv-00415-LPS) Joint Claim Construction Brief, (118 in 1:20-cv-00445-LPS) Joint Claim Construction Brief, (136 in 1:19-cv-02053-LPS) Joint Claim Construction Brief, (253 in 1:20-md-02930-LPS) Joint Claim Construction Brief, (239 in 1:19-cv-01979-LPS) Joint Claim Construction Brief, (66 in 1:20-cv-00074-LPS) Joint Claim Construction Brief (Volume 2 -- Exhibits 1-57) by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit 1-29, # (2) Exhibit 35-43, # (3) Exhibit 44, # (4) Exhibit 45-57)(Silver, Daniel)
May 21, 2021 120 Exhibit 1-29 (200)
May 21, 2021 120 Exhibit 35-43 (83)
May 21, 2021 120 Exhibit 44 (54)
May 21, 2021 120 Exhibit 45-57 (180)
May 21, 2021 121 Letter (2)
Docket Text: Letter to The Honorable Chief Judge Leonard P. Stark from Daniel M. Silver, Esq. regarding Claim Construction Hearing. (Silver, Daniel)
May 20, 2021 117 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Defendants Objection to Plaintiffs Notice of Deposition of Raymond Butcher, Ph.D., Pursuant to Fed. R. Civ. P. 30(b)(1) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories, Inc..(Stamoulis, Stamatios)
May 19, 2021 116 Statement (6)
Docket Text: STATEMENT re (241 in 1:20-md-02930-LPS, 228 in 1:19-cv-01979-LPS) Letter Novartis's Comments on Defendants' Technology Tutorial by Novartis Pharmaceuticals Corporation. (Silver, Daniel)
May 18, 2021 115 Main Document (13)
Docket Text: STIPULATION and [Proposed] Order Regarding Plaintiff Novartis Pharmaceuticals Corporation's Amended Complaints by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-N)(Silver, Daniel)
May 18, 2021 115 Exhibit A-N (614)
May 17, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (82 in 1:19-cv-02021-LPS, 60 in 1:20-cv-00074-LPS, 112 in 1:20-cv-00445-LPS, 247 in 1:20-md-02930-LPS, 233 in 1:19-cv-01979-LPS, 63 in 1:20-cv-00415-LPS, 12 in 1:21-cv-00229-LPS, 130 in 1:19-cv-02053-LPS) STIPULATION TO EXTEND TIME for Paintiff to Amend or Supplement Pleadings to May 18, 2021 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 5/17/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl)
May 17, 2021 N/A Order (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that: (1) the claim construction hearing will be held remotely; (2) the claim construction hearing is RESCHEDULED to June 8, 2021 at 10:00 a.m.; and (3) the parties shall advise the Court, simultaneously with filing their joint claim construction brief, of the number of hours they request for the hearing and whether they prefer to proceed by video or telephone conference. ORDERED by Judge Leonard P. Stark on 5/17/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl)
May 17, 2021 114 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of Defendants' Joint Sur-Reply Claim Construction Brief [with Exhibit 57]; and, (ii) the Declaration of Raymond Butcher, Ph.D. filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
May 14, 2021 112 Stipulation to EXTEND Time (13)
Docket Text: STIPULATION TO EXTEND TIME Deadline for Paintiff to Amend or Supplement Pleadings to May 18, 2021 - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
May 11, 2021 111 Notice (Other) (5)
Docket Text: NOTICE of Deposition of Raymond Butcher, Ph.D., Pursuant to Fed. R. Civ. P. 30(b)(1) by Novartis Pharmaceuticals Corporation (Silver, Daniel)
May 5, 2021 110 Letter (1)
Docket Text: Letter to The Honorable Chief Judge Leonard P. Stark from Daniel M. Silver, Esq. regarding Plaintiff's Technology Tutorial. (Silver, Daniel)
May 3, 2021 109 Notice Requesting Removal of Co-Counsel (1)
Docket Text: NOTICE requesting Clerk to remove Karen L. Carroll as co-counsel. Reason for request: no longer with the firm of Parker Poe Adams & Bernstein LLP. (Palapura, Bindu)
Apr 29, 2021 108 Notice of Service (16)
Docket Text: NOTICE OF SERVICE of (1) Novartis's Reply Claim Construction Brief, (2) Declaration of Laura K. Fishwick, Esq., and (3) Reply Declaration of Alexander M. Klibanov, Ph.D. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Apr 21, 2021 107 Notice of Service (15)
Docket Text: NOTICE OF SERVICE of Novartis's Objections to Defendants' Notice of Deposition of Alexander M. Klibanov, Ph.D., Pursuant to Fed. R. Civ. P. 30(b)(1) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Apr 16, 2021 106 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of DEFENDANT MYLAN PHARMACEUTICALS PRODUCTION OF DOCUMENTS LABELED MYLAN_SACVAL_00061802-MYLAN_SACVAL_00158295 [HIGHLY CONFIDENTIAL OUTSIDE ATTORNEY'S EYES ONLY] filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Mar 31, 2021 105 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of (i) Defendants' Joint Responsive Claim Construction Brief [with exhibits]; and, (ii) Declaration of Raymond Butcher, Ph.D. [with exhibits] filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Mar 30, 2021 104 Notice to Take Deposition (11)
Docket Text: NOTICE to Take Deposition of Alexander M. Klibanov, Ph.D., on May 5, 2021 filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Mar 16, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (223 in 1:20-md-02930-LPS, 52 in 1:20-cv-00074-LPS, 74 in 1:19-cv-02021-LPS, 103 in 1:20-cv-00445-LPS, 215 in 1:19-cv-01979-LPS, 122 in 1:19-cv-02053-LPS, 55 in 1:20-cv-00415-LPS) STIPULATION and [Proposed] Order Extending Deadline to Amend the Pleadings; (51 in 1:20-cv-00074-LPS, 121 in 1:19-cv-02053-LPS, 213 in 1:19-cv-01979-LPS, 54 in 1:20-cv-00415-LPS, 73 in 1:19-cv-02021-LPS, 102 in 1:20-cv-00445-LPS, 221 in 1:20-md-02930-LPS) STIPULATION and [Proposed] Order Extending Time to Meet and Confer Regarding Depositions. Signed by Judge Leonard P. Stark on 3/15/21. Associated Cases: 1:19-cv-01979-LPS et al. (ntl)
Mar 12, 2021 103 Stipulation (12)
Docket Text: STIPULATION and [Proposed] Order Extending Deadline to Amend the Pleadings re (45 in 1:19-cv-02021-LPS, 33 in 1:20-cv-00415-LPS, 102 in 1:20-md-02930-LPS, 29 in 1:20-cv-00074-LPS, 78 in 1:19-cv-02053-LPS, 137 in 1:19-cv-01979-LPS, 74 in 1:20-cv-00445-LPS) Scheduling Order,, by Mylan Pharmaceuticals Inc.. (Palapura, Bindu)
Mar 11, 2021 102 Stipulation (12)
Docket Text: STIPULATION and [Proposed] Order Extending Time to Meet and Confer Regarding Depositions by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
Mar 4, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (213 in 1:20-md-02930-LPS, 206 in 1:19-cv-01979-LPS, 52 in 1:20-cv-00415-LPS, 99 in 1:20-cv-00445-LPS, 71 in 1:19-cv-02021-LPS, 119 in 1:19-cv-02053-LPS, 49 in 1:20-cv-00074-LPS) STIPULATION TO EXTEND TIME for the substantial completion of document production to April 14, 2021 filed by Biocon Limited, Biocon Pharma, Inc., Alkem Laboratories Ltd., Biocon Pharma Limited, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. Signed by Judge Leonard P. Stark on 3/3/21. Associated Cases: 1:19-cv-01979-LPS et al. (ntl)
Mar 4, 2021 101 Notice of Service (14)
Docket Text: NOTICE OF SERVICE of (1) Novartiss Opening Claim Construction Brief and (2) Declaration of Alexander M. Klibanov filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Mar 1, 2021 99 Stipulation to EXTEND Time (12)
Docket Text: STIPULATION TO EXTEND TIME for the substantial completion of document production to April 14, 2021 - filed by Alkem Laboratories Ltd., Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc.. (Dorsney, Kenneth)
Mar 1, 2021 100 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (1) Novartis's Objections and Responses to Defendant Mylan Pharmaceuticals Inc.'s First Set of Individual Interrogatories (Nos. 1-4) and (2) Novartis's Objections and Responses to Defendant Mylan Pharmaceuticals Inc.'s First Set of Individual Requests for Production (Nos. 1-2) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Feb 26, 2021 98 Notice Requesting Removal of Co-Counsel (2)
Docket Text: NOTICE requesting Clerk to remove Micheal L. Binns as co-counsel. Reason for request: no longer with the firm of Parker Poe Adams & Bernstein LLP. (Palapura, Bindu) Modified on 2/26/2021 (amf).
Feb 17, 2021 96 Claim Construction Chart (23)
Docket Text: CLAIM Construction Chart by Novartis Pharmaceuticals Corporation. (Silver, Daniel)
Feb 17, 2021 97 Main Document (15)
Docket Text: APPENDIX re (96 in 1:20-cv-00445-LPS, 117 in 1:19-cv-02053-LPS, 199 in 1:19-cv-01979-LPS, 69 in 1:19-cv-02021-LPS, 50 in 1:20-cv-00415-LPS, 205 in 1:20-md-02930-LPS, 47 in 1:20-cv-00074-LPS) Claim Construction Chart by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit 1-17, # (2) Exhibit 18-25, # (3) Exhibit 26-36)(Silver, Daniel)
Feb 17, 2021 97 Exhibit 1-17 (163)
Feb 17, 2021 97 Exhibit 18-25 (146)
Feb 17, 2021 97 Exhibit 26-36 (92)
Feb 16, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (68 in 1:19-cv-02021-LPS, 196 in 1:19-cv-01979-LPS, 115 in 1:19-cv-02053-LPS, 201 in 1:20-md-02930-LPS, 49 in 1:20-cv-00415-LPS, 95 in 1:20-cv-00445-LPS, 46 in 1:20-cv-00074-LPS) STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Joint Claim Construction Chart to February 17, 2021 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 2/16/21. Associated Cases: 1:19-cv-01979-LPS et al. (ntl)
Feb 12, 2021 95 Stipulation to EXTEND Time (11)
Docket Text: STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Joint Claim Construction Chart to February 17, 2021 - filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel)
Feb 1, 2021 94 Notice of Service (15)
Docket Text: NOTICE OF SERVICE of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Jan 29, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (198 in 1:20-md-02930-LPS) (44 in 1:20-cv-00074-LPS, 92 in 1:20-cv-00445-LPS, 47 in 1:20-cv-00415-LPS, 113 in 1:19-cv-02053-LPS, 66 in 1:19-cv-02021-LPS, 194 in 1:19-cv-01979-LPS) STIPULATION TO EXTEND TIME for completion of production of documents to March 15, 2021 filed by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc. Signed by Judge Leonard P. Stark on 1/28/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl)
Jan 29, 2021 93 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s First Set Of Individual Interrogatories (Nos. 1-4) To Plaintiff Novartis Pharmaceuticals Corporation [Highly Confidential Attorneys' Eyes Only]; and Defendant Mylan Pharmaceuticals Inc.'s First Set Of Individual Requests For Production (Nos. 1-2) To Plaintiff Novartis Pharmaceuticals Corporation [Highly Confidential Attorneys' Eyes Only] filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Jan 27, 2021 92 Stipulation to EXTEND Time (12)
Docket Text: STIPULATION TO EXTEND TIME for completion of production of documents to March 15, 2021 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Seaman, John)
Jan 22, 2021 91 Notice of Service (14)
Docket Text: NOTICE OF SERVICE of (1) Novartis's First Supplemental Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-7) and (2) Novartis's First Set of Common Interrogatories to Defendants filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Jan 15, 2021 90 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Defendant Crystal Pharmaceutical (Suzhou) Co., Ltd.s First Set of Individual Interrogatories (Nos. 1-3) to Plaintiff Novartis Pharmaceuticals Corporation filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Jan 14, 2021 89 Notice (Other) (2)
Docket Text: NOTICE of Change of Address of Certain Pro Hac Vice Counsel by Mylan Pharmaceuticals Inc. (Moore, David)
Jan 13, 2021 88 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories to Mylan Pharmaceuticals Inc. (Nos. 3-5) [Highly Confidential-Attorneys' Eyes Only] filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Jan 9, 2021 87 Notice of Service (6)
Docket Text: NOTICE OF SERVICE of Defendants Preliminary Claim Constructions and Supporting Evidence filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc., Dr. Reddys Laboratories, Inc..(Stamoulis, Stamatios)
Dec 10, 2020 86 Notice (Other) (1)
Docket Text: NOTICE of Withdrawal of Tracey E. Timlin by Mylan Pharmaceuticals Inc. (Moore, David)
Dec 7, 2020 85 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants' Joint Initial Invalidity Contentions Under Local Patent Rules filed by Mylan Pharmaceuticals Inc..(Moore, David)
Nov 25, 2020 84 Disclosure Statement (1)
Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc.. (Palapura, Bindu)
Nov 19, 2020 83 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Responses And Objections To Novartis's Second Set Of Interrogatories To Mylan Pharmaceuticals Inc. (Nos. 3-5) [Highly Confidential Attorneys' Eyes Only] filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Nov 16, 2020 82 Notice of Service (13)
Docket Text: NOTICE OF SERVICE of Novartis's Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-7) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Oct 22, 2020 81 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Responses and Objections to Novartis's First Set of Interrogatories to Mylan Pharmaceuticals Inc. (Nos. 1-2) [Highly Confidential-Attorneys' Eyes Only] filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Oct 21, 2020 80 Notice of Service (20)
Docket Text: NOTICE OF SERVICE of (1) Novartiss Second Set of Interrogatories to Defendants (Nos. 3-5) and (2) Plaintiffs Initial Infringement Chart Against Defendants filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Oct 20, 2020 79 Notice of Service (14)
Docket Text: NOTICE OF SERVICE of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for the Production of Documents and Things (Nos. 1-108) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Oct 15, 2020 78 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Defendants First Set of Interrogatories (Nos. 1-7) to Plaintiff Novartis Pharmaceuticals Corporation filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc., Dr. Reddys Laboratories, Inc..(Stamoulis, Stamatios)
Oct 2, 2020 77 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Responses And Objections To Novartis's Second Set Of Requests To Mylan Pharmaceuticals Inc. For The Production Of Documents And Things (Nos. 15-61) [Highly Confidential Attorneys' Eyes Only]; Mylan Pharmaceuticals Inc.'s Responses And Objections To Novartis's Third Set Of Requests To Mylan Pharmaceuticals Inc. For The Production Of Documents And Things (Nos. 62-74) [Highly Confidential Attorneys' Eyes Only] filed by Mylan Pharmaceuticals Inc..(Timlin, Tracey)
Sep 28, 2020 76 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Responses and Objections to Novartis's First Set of Requests to Mylan Pharmaceuticals Inc. for the Production of Documents and Things [Highly Confidential-Attorneys' Eyes Only] filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Sep 22, 2020 75 Notice of Service (17)
Docket Text: NOTICE OF SERVICE of Novartis's First Set of Interrogatories to Defendants (Nos. 1-2) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Sep 18, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (24 in 1:20-cv-00074-LPS, 80 in 1:20-md-02930-LPS, 67 in 1:19-cv-02053-LPS, 40 in 1:19-cv-02021-LPS, 68 in 1:20-cv-00445-LPS, 122 in 1:19-cv-01979-LPS, 26 in 1:20-cv-00415-LPS) STIPULATED PROTECTIVE ORDER. Signed by Judge Leonard P. Stark on 9/14/20. Associated Cases: 1:19-cv-01979-LPS et al. (ntl)
Sep 18, 2020 74 Scheduling Order (24)
Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 10/20/2021. Status Report due by 11/3/2021. Joint Claim Construction Brief due by 5/21/2021. A Markman Hearing is set for 6/7/2021 at 12:30 PM in Courtroom 6B before Judge Leonard P. Stark. A Final Pretrial Conference is set for 8/26/2022 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 12-day Bench Trial is set for 9/8/2022 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 9/14/20. Associated Cases: 1:19-cv-01979-LPS et al. (ntl)
Sep 17, 2020 73 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Defendants' First Set of Joint Requests for the Production of Documents and Things (Nos. 1-108) to Plaintiff Novartis Pharmaceuticals Corporation filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
Sep 11, 2020 72 Proposed Order (26)
Docket Text: PROPOSED ORDER Scheduling by Novartis Pharmaceuticals Corporation. (Silver, Daniel)
Sep 9, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (42 in 1:19-cv-02021-LPS, 71 in 1:20-cv-00445-LPS, 73 in 1:19-cv-02053-LPS, 132 in 1:19-cv-01979-LPS, 26 in 1:20-cv-00074-LPS, 29 in 1:20-cv-00415-LPS, 95 in 1:20-md-02930-LPS) STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Revised Proposed Scheduling Order to September 11, 2020 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 9/8/20. Associated Cases: 1:20-md-02930-LPS et al. (ntl)
Sep 4, 2020 71 Stipulation to EXTEND Time (10)
Docket Text: STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Revised Proposed Scheduling Order to September 11, 2020 - filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel)
Sep 3, 2020 70 Notice of Service (19)
Docket Text: NOTICE OF SERVICE of (1) Novartiss Second Set of Requests to Defendants for the Production of Documents and Things ; and (2) Novartiss Third Set of Requests to Defendants for the Production of Documents and Things filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Sep 1, 2020 69 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Disclosure Pursuant to Court's August 24, 2020 Oral Order filed by Mylan Pharmaceuticals Inc..(Moore, David)
Aug 31, 2020 68 Proposed Order (30)
Docket Text: PROPOSED ORDER Stipulated Protective Order by Novartis Pharmaceuticals Corporation. (Silver, Daniel)
Aug 28, 2020 67 Notice of Service (19)
Docket Text: NOTICE OF SERVICE of Novartis's First Set of Requests to Defendants for the Production of Documents and Things filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Aug 25, 2020 N/A Order (0)
Docket Text: ORAL ORDER: For the reasons stated during the teleconference on August 24, 2020, IT IS HEREBY ORDERED THAT a revised version of the proposed protective order is due on August 31, 2020, and a revised version of the proposed scheduling order is due on September 4, 2020, both incorporating the dates and decisions the Court announced during the hearing, including that the bench trial (not to exceed 12 days) will be held between September 8 and 23, 2022. ORDERED by Judge Leonard P. Stark on 8/25/20. Associated Cases: 1:19-cv-01979-LPS et al. (ntl)
Aug 24, 2020 N/A Telephone Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 8/24/2020. (Court Reporter B. Gaffigan.) Associated Cases: 1:19-cv-01979-LPS et al. (ntl)
Aug 20, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (61 in 1:19-cv-02053-LPS, 69 in 1:20-md-02930-LPS, 63 in 1:20-cv-00445-LPS, 19 in 1:20-cv-00074-LPS, 112 in 1:19-cv-01979-LPS, 21 in 1:20-cv-00415-LPS, 33 in 1:19-cv-02021-LPS) STIPULATION TO EXTEND TIME for parties to submit a proposed scheduling order, proposed protective order, and letters regarding the disputed provisions to August 18, 2020 at 12:00 p.m. EST filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 8/20/20. Associated Cases: 1:19-cv-01979-LPS et al. (ntl)
Aug 18, 2020 64 Main Document (10)
Docket Text: Joint Letter to The Honorable Leonard P. Stark from Daniel M. Silver, Esq. regarding Regarding Disputed Provisions of Proposed Scheduling Order. (Attachments: # (1) Exhibit A-K, # (2) Text of Proposed Order [Reflecting Parties' Disagreements])(Silver, Daniel)
Aug 18, 2020 64 Exhibit A-K (224)
Aug 18, 2020 64 Text of Proposed Order [Reflecting Parties' Disagreements] (37)
Aug 18, 2020 65 Main Document (9)
Docket Text: Joint Letter to The Honorable Leonard P. Stark from Daniel M. Silver, Esq. regarding Disputed Provisions of Proposed Protective Order. (Attachments: # (1) Exhibit 1-2, # (2) Text of Proposed Order [Reflecting Parties' Disagreements])(Silver, Daniel)
Aug 18, 2020 65 Exhibit 1-2 (16)
Aug 18, 2020 65 Text of Proposed Order [Reflecting Parties' Disagreements] (49)
Aug 17, 2020 63 Stipulation to EXTEND Time (11)
Docket Text: STIPULATION TO EXTEND TIME for parties to submit a proposed scheduling order, proposed protective order, and letters regarding the disputed provisions to August 18, 2020 at 12:00 p.m. EST - filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel)
Jul 29, 2020 N/A Order Setting Teleconference (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that a Scheduling and Discovery Telephone Conference is set for August 24, 2020 at 9:30 AM. The parties can access the teleconference by dialing 877-336-1829 and using the access code 1408971. The parties shall confer and submit a proposed schedule, proposed protective order, and letter(s) regarding the disputed provisions, all by no later than August 17. ORDERED by Judge Leonard P. Stark on 7/29/20. Associated Cases: 1:20-md-02930-LPS, 1:19-cv-01979-LPS, 1:19-cv-02021-LPS, 1:19-cv-02053-LPS, 1:20-cv-00445-LPS (ntl)
Jul 27, 2020 61 Notice of Service (13)
Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Rule 26(A)(1) Initial Disclosures; (2) Plaintiffs Initial Paragraph 3 Disclosures Regarding Electronic Systems Information; and (3) Plaintiffs Identification of Asserted patents and Accused Products pursuant to Paragraph 4(a) of the Delaware Default Standard for Discovery filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Jul 6, 2020 60 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Core Technical Documents [Highly Confidential-Outside Attorney's Eyes Only] filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Jun 11, 2020 59 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s Initial Disclosures Pursuant To Rule 26(A)(1) And Paragraph 3 Of The Delaware Default Standard For Discovery filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Jun 1, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (29 in 1:20-md-02930-LPS, 58 in 1:20-cv-00445-LPS) MOTION for Pro Hac Vice Appearance of Attorney Tasneem A. Dharamsi of Parker Poe & Bernstein LLP filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 6/1/20. Associated Cases: 1:20-cv-00445-LPS, 1:20-md-02930-LPS (ntl)
May 29, 2020 58 Motion for Leave to Appear Pro Hac Vice (3)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Tasneem A. Dharamsi of Parker Poe & Bernstein LLP - filed by Mylan Pharmaceuticals Inc.. (Palapura, Bindu)
Apr 2, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (56 in 1:20-cv-00445-LPS, 9 in 1:20-md-02930-LPS) MOTION for Pro Hac Vice Appearance of Attorney Nichols N. Kallas, Christina Schwarz, and Jared L. Stringham filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 4/2/20. Associated Cases: 1:20-cv-00445-LPS, 1:20-md-02930-LPS (ntl)
Apr 2, 2020 56 Main Document (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nichols N. Kallas, Christina Schwarz, and Jared L. Stringham - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Certifications for Nichols N. Kallas, Christina Schwarz, and Jared L. Stringham)(Silver, Daniel)
Apr 2, 2020 56 Certifications for Nichols N. Kallas, Christina Schwarz, and Jared L. Stringham (3)
Apr 2, 2020 57 Answer to Counterclaim (16)
Docket Text: ANSWER to [39] Answer to Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Apr 1, 2020 51 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by David Ellis Moore on behalf of Mylan Pharmaceuticals Inc. (Moore, David)
Apr 1, 2020 52 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Pharmaceuticals Inc. (Palapura, Bindu)
Apr 1, 2020 53 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by Tracey E. Timlin on behalf of Mylan Pharmaceuticals Inc. (Timlin, Tracey)
Apr 1, 2020 54 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by Daniel M. Silver on behalf of Novartis Pharmaceuticals Corporation (Silver, Daniel)
Apr 1, 2020 55 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by Alexandra M. Joyce on behalf of Novartis Pharmaceuticals Corporation (Joyce, Alexandra)
Mar 31, 2020 N/A Remark - MDL Member (0)
Docket Text: NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. (kmd)
Mar 31, 2020 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: Case from West VA was inadvertently opened as 20-MD-445. The proper case number is 20-CV-445. Associated Cases: 1:20-cv-00445-LPS et al.(rwc)
Mar 31, 2020 49 Main Document Public Docket Sheet (9)
Docket Text: Record of case transferred in from District of West Virginia Northern; Case Number in Other District: 1:19-cv-00201. Copy of Docket Sheet and original file.
Mar 31, 2020 49 *Restricted* (9)
Mar 31, 2020 50 Remark - MDL Notice to Counsel (1)
Docket Text: NOTICE TO COUNSEL: MDL No. 1:20-md-445 has been opened and assigned to the Honorable Leonard P. Stark. Attorneys of record who will be electronically filing documents may use the attached form to register for a CM/ECF login and password or they may continue to go through their Local Counsel. Please see the docket for further entries. (kmd)
Mar 30, 2020 N/A Case Transferred Out to Another District (0)
Docket Text: Case transferred to District of Delawarere MDL 2930. Entire Case file electronically transmitted. (wrr) Modified on 3/30/2020 to correct docket text (wrr). NEF regenerated. [Transferred from West Virginia Northern on 3/31/2020.]
Mar 30, 2020 48 Order (4)
Docket Text: CERTIFIED COPY OF JPML TRANSFER ORDER re: pldg. ([1] in MDL No. 2930) Transferring 1 action(s) to Judge Judge Leonard P. Stark in the D. Delaware. Signed by Judge Ellen Segal Huvelle, Acting Chair, PANEL ON MULTIDISTRICT LITIGATION, on 3/27/2020. Associated Cases: MDL No. 2930, DE/1:19-cv-01979, DE/1:19-cv-02021, DE/1:19-cv-02053, WVN/1:19-cv-00201. (wrr) [Transferred from West Virginia Northern on 3/31/2020.]
Mar 16, 2020 41 Main Document (4)
Docket Text: MOTION for Leave to Appear Pro Hac Vice (Karen L. Carroll) by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) [Transferred from West Virginia Northern on 3/31/2020.]
Mar 16, 2020 41 Proposed Order (1)
Mar 16, 2020 42 Main Document (4)
Docket Text: MOTION for Leave to Appear Pro Hac Vice (Robert L. Florence) by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) [Transferred from West Virginia Northern on 3/31/2020.]
Mar 16, 2020 42 Proposed Order (1)
Mar 16, 2020 43 Main Document (4)
Docket Text: MOTION for Leave to Appear Pro Hac Vice (Micheal L. Binns) by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) [Transferred from West Virginia Northern on 3/31/2020.]
Mar 16, 2020 43 Proposed Order (1)
Mar 16, 2020 45 Order on Motion to Appear Pro Hac Vice (1)
Docket Text: ORDER granting [43] Motion for Leave to Appear Pro Hac Vice for Attorney Michael L. Binns. Signed by Senior Judge Irene M. Keeley on 3/16/2020. (Copy counsel of record)(jmm) [Transferred from West Virginia Northern on 3/31/2020.]
Mar 16, 2020 46 Order on Motion to Appear Pro Hac Vice (1)
Docket Text: ORDER granting [41] Motion for Leave to Appear Pro Hac Vice for attorney Karen L. Carroll. Signed by Senior Judge Irene M. Keeley on 3/16/2020. (Copy counsel of record)(jmm) [Transferred from West Virginia Northern on 3/31/2020.]
Mar 16, 2020 47 Order on Motion to Appear Pro Hac Vice (1)
Docket Text: ORDER granting [42] Motion for Leave to Appear Pro Hac Vice for Attorney Robert L. Florence. Signed by Senior Judge Irene M. Keeley on 3/16/2020. (Copy counsel of record)(jmm) [Transferred from West Virginia Northern on 3/31/2020.]
Mar 12, 2020 39 Answer to Complaint (30)
Docket Text: ANSWER to [1] Complaint, AFFIRMATIVE DEFENSES, COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Mylan Pharmaceuticals Inc..(O'Brien, William) [Transferred from West Virginia Northern on 3/31/2020.]
Mar 12, 2020 40 Disclosure Statement (2)
Docket Text: Corporate Disclosure Statement by Mylan Pharmaceuticals Inc. identifying Corporate Parent Mylan Inc., Corporate Parent Mylan N.V. for Mylan Pharmaceuticals Inc... (O'Brien, William) [Transferred from West Virginia Northern on 3/31/2020.]
Feb 5, 2020 37 Stipulation and Order (4)
Docket Text: STIPULATION AND ORDER by Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (O'Brien, William) [Transferred from West Virginia Northern on 3/31/2020.]
Feb 5, 2020 38 Stipulation and Order (3)
Docket Text: STIPULATION AND ORDER. It is stipulated between the parties that Plaintiff dismisses its claims against Mylan Inc. and Mylan Laboratories Limited in this action. Signed by Senior Judge Irene M. Keeley on 2/5/2020. (wrr)[Transferred from West Virginia Northern on 3/31/2020.]
Jan 24, 2020 36 Order (2)
Docket Text: ORDER GRANTING PLAINTIFF'S MOTION TO EXTEND CASE SCHEDULE [DKT. NO. [30]]. The Court GRANTS Novartis's motion (Dkt. No. [30]) and EXTENDS the current dates and deadlines as follows: Mylan to answer, move, or otherwise respond to Novartis's complaint on or before April 6, 2020; Rule 26 Meeting to be held by 4/20/2020; Rule 26 Meeting Report due by 5/1/2020; Scheduling Conference set for 5/15/2020 12:15 PM, by telephone; Discovery due by 5/22/2020. Signed by Senior Judge Irene M. Keeley on 1/24/2020. (wrr) [Transferred from West Virginia Northern on 3/31/2020.]
Jan 23, 2020 35 Response to Motion (3)
Docket Text: RESPONSE to Motion re [30] MOTION Extend the Current Scheduled Dates in this Case by 60 Days (non-Opposition by Mylan) filed by Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (Copland, Gordon)[Transferred from West Virginia Northern on 3/31/2020.]
Jan 17, 2020 34 Stipulation and Order (3)
Docket Text: STIPULATION AND ORDER FOR EXTENSION OF TIME TO RESPOND TO PLAINTIFF'S [30] MOTION TO EXTEND CURRENT CASE SCHEDULE AND SECOND STIPULATION FOR EXTENSION OF TIME TO ANSWER, MOVE OR OTHERWISE RESPOND TO COMPLAINT. By agreement of the parties, the deadline for Mylan to respond to Plaintiff's motion will be extended from January 16, 2020 through and including January 23, 2020, the deadline for Plaintiff to reply to Mylan's response to Plaintiff's motion will be extended from January 23, 2020 through and including January 30, 2020, and the deadline for Mylan to answer, move, or otherwise respond to the Complaint will be extended from January 21, 2020 through and including February 6, 2020. Signed by Senior Judge Irene M. Keeley on 1/17/2020. (wrr) [Transferred from West Virginia Northern on 3/31/2020.]
Jan 16, 2020 33 Stipulation and Order (3)
Docket Text: STIPULATION AND ORDER FOR EXTENSION OF TIME TO RESPOND TO PLAINTIFF'S MOTION TO EXTEND CURRENT CASE SCHEDULE AND SECOND STIPULATION FOR EXTENSION OF TIME TO ANSWER, MOVE OR OTHERWISE RESPOND TO COMPLAINT by Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (O'Brien, William) [Transferred from West Virginia Northern on 3/31/2020.]
Jan 3, 2020 32 Stipulation (2)
Docket Text: STIPULATION For Extension of Time to Answer, Move or Otherwise Response to Complaint by Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (O'Brien, William) [Transferred from West Virginia Northern on 3/31/2020.]
Jan 2, 2020 30 Motion for Extension of Time (4)
Docket Text: MOTION Extend the Current Scheduled Dates in this Case by 60 Days by Novartis Pharmaceuticals Corporation. (Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Jan 2, 2020 31 MEMORANDUM in Support (15)
Docket Text: MEMORANDUM in Support by Novartis Pharmaceuticals Corporation re [30] MOTION Extend the Current Scheduled Dates in this Case by 60 Days . (Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Dec 20, 2019 29 Main Document (8)
Docket Text: Courtesy Copy of Motion to Transfer filed with the JDML. (Attachments: # (1) Attachment, # (2) Attachment, # (3) Attachment, # (4) Attachment, # (5) Attachment, # (6) Attachment, # (7) Attachment, # (8) Attachment, # (9) Attachment)(mh)[Transferred from West Virginia Northern on 3/31/2020.]
Dec 20, 2019 29 Attachment (11)
Dec 20, 2019 29 Attachment (3)
Dec 20, 2019 29 Attachment (2)
Dec 20, 2019 29 Attachment (3)
Dec 20, 2019 29 Attachment (12)
Dec 20, 2019 29 Attachment (101)
Dec 20, 2019 29 Attachment (35)
Dec 20, 2019 29 Attachment (70)
Dec 20, 2019 29 Attachment (22)
Dec 16, 2019 28 Order (3)
Docket Text: FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING:

***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm

Rule 26 Meeting to be held by 2/4/2020. Rule 26 Meeting Report due by 2/18/2020. Scheduling Conference set for 3/3/2020, at 1:30 PM, in Judge Keeley Chambers before Senior Judge Irene M. Keeley. Discovery due by 3/10/2020. Signed by Senior Judge Irene M. Keeley on 12/16/2019. (dk) [Transferred from West Virginia Northern on 3/31/2020.]

Dec 15, 2019 27 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by William J O'Brien on behalf of Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. (O'Brien, William) [Transferred from West Virginia Northern on 3/31/2020.]
Dec 12, 2019 24 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE Returned Executed by Novartis Pharmaceuticals Corporation. Mylan Pharmaceuticals Inc. waiver sent on 11/15/2019, answer due 1/14/2020. (Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Dec 12, 2019 25 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE Returned Executed by Novartis Pharmaceuticals Corporation. Mylan Inc. waiver sent on 11/15/2019, answer due 1/14/2020. (Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Dec 12, 2019 26 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE Returned Executed by Novartis Pharmaceuticals Corporation. Mylan Laboratories Limited waiver sent on 11/15/2019, answer due 1/14/2020. (Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 6, 2019 16 Order on Motion to Appear Pro Hac Vice (1)
Docket Text: ORDER granting [12] Motion for Shannon K. Clark to Appear Pro Hac Vice on behalf of Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 6, 2019 17 Order on Motion to Appear Pro Hac Vice (1)
Docket Text: ORDER granting [13] Motion for Laura K. Fishwick to Appear Pro Hac Vice on behalf of Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 6, 2019 18 Order on Motion to Appear Pro Hac Vice (1)
Docket Text: ORDER granting [10] Motion for Susanne Flanders to Appear Pro Hac Vice on behalf of Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 6, 2019 19 Order on Motion to Appear Pro Hac Vice (1)
Docket Text: ORDER granting [7] Motion for Nicholas N. Kallas to Appear Pro Hac Vice on behalf of the Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 6, 2019 20 Order on Motion to Appear Pro Hac Vice (1)
Docket Text: ORDER granting [9] Motion for Christopher E. Loh to appear Pro Hac Vice on behalf of Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 6, 2019 21 Order on Motion to Appear Pro Hac Vice (1)
Docket Text: ORDER granting [14] Motion for Gregory J. Manas to Appear Pro Hac Vice on behalf of Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 6, 2019 22 Order on Motion to Appear Pro Hac Vice (1)
Docket Text: ORDER granting [8] Motion for Christina Anne Larissa Schwarz to Appear Pro Hac Vice on behalf of the Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 6, 2019 23 Order on Motion to Appear Pro Hac Vice (1)
Docket Text: ORDER granting [11] Motion for Jared L. Stringham to Appear Pro Hac Vice on behalf of Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 5, 2019 7 Main Document (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice of Nicholas N. Kallas by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 5, 2019 7 Text of Proposed Order (1)
Nov 5, 2019 8 Main Document (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice of Christina Anne Larissa Schwarz by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 5, 2019 8 Text of Proposed Order (1)
Nov 5, 2019 9 Main Document (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice of Christopher E. Loh by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 5, 2019 9 Text of Proposed Order (1)
Nov 5, 2019 10 Main Document (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice of Susanne Flanders by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 5, 2019 10 Text of Proposed Order (1)
Nov 5, 2019 11 Main Document (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice of Jared L. Stringham by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 5, 2019 11 Text of Proposed Order (1)
Nov 5, 2019 12 Main Document (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice of Shannon K. Clark by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 5, 2019 12 Text of Proposed Order (1)
Nov 5, 2019 13 Main Document (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice of Laura K. Fishwick by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 5, 2019 13 Text of Proposed Order (1)
Nov 5, 2019 14 Main Document (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice of Gregory J. Manas by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 3/31/2020.]
Nov 5, 2019 14 Text of Proposed Order (1)
Oct 30, 2019 1 Main Document (15)
Docket Text: COMPLAINT against All Defendants, filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A - Patent Information, # (2) Exhibit B - Patent Information, # (3) Exhibit C - Patent Information, # (4) Exhibit D - Patent Information, # (5) Civil Cover Sheet)(dk) [Transferred from West Virginia Northern on 3/31/2020.]
Oct 30, 2019 1 Exhibit A - Patent Information (11)
Oct 30, 2019 1 Exhibit B - Patent Information (11)
Oct 30, 2019 1 Exhibit C - Patent Information (21)
Oct 30, 2019 1 Exhibit D - Patent Information (20)
Oct 30, 2019 1 Civil Cover Sheet (2)
Oct 30, 2019 3 Disclosure Statement (2)
Docket Text: Corporate Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (dk) [Transferred from West Virginia Northern on 3/31/2020.]
Oct 30, 2019 4 ANDA Form (2)
Docket Text: Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA) filed by Novartis Pharmaceuticals Corporation. (dk) [Transferred from West Virginia Northern on 3/31/2020.]
Oct 30, 2019 5 Patent/Trademark Report to Commissioner (1)
Docket Text: REPORT to USPTO on the filing or determination of an action regarding re [1] Complaint. (dk) [Transferred from West Virginia Northern on 3/31/2020.]
Oct 30, 2019 6 Notice (Other) (1)
Docket Text: VERIFICATION OF ATTORNEY ADMISSION to Attorneys Schwarz, Flanders, Clark, Fishwick, and Manas. (dk) [Transferred from West Virginia Northern on 3/31/2020.]
Menu